Literature DB >> 1662855

Discrimination of herpes simplex virus types 1 and 2 cerebral infections in a rat model.

T Bergström1, B Svennerholm, N Conradi, P Horal, A Vahlne.   

Abstract

A rat model was used to evaluate intertypic differences after intracranial (i.c.) inoculation of herpes simplex virus (HSV) types 1 and 2 strains with regard to neurovirulence and neuropathology, and influence of age on susceptibility. In adult rats, HSV-1 strains were more virulent than HSV-2 strains. HSV-1 replicated to higher titers in the central nervous system (CNS) of rats, as compared with HSV-2. In rats of less than 2-3 weeks of age, HSV-1 and HSV-2 were equally virulent, but morphological examination of rat brains showed type-specific differences in pathology and viral distribution already at the early postnatal stage. After HSV-1 infection, neuronal infection of the hippocampus, followed by cortical infection and edematous destruction dominated, while a preponderance of meningitis and invasive encephalitis was seen after HSV-2 infection. We suggest that the rat might be a useful model for human HSV infection in the CNS with discrimination between HSV-1 and HSV-2 infections, also at the early postnatal stage.

Entities:  

Mesh:

Year:  1991        PMID: 1662855     DOI: 10.1007/bf00296551

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

1.  Differentiation between herpes simplex virus type 1 and type 2 strains by immunoelectroosmophoresis.

Authors:  S Jeansson
Journal:  Appl Microbiol       Date:  1972-07

2.  Typing of herpes simplex virus by an enzyme-linked immunosorbent assay with monoclonal antibodies.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.

Authors:  R Whitley; A D Lakeman; A Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

4.  Intravenous acyclovir for the treatment of primary genital herpes.

Authors:  L Corey; K H Fife; J K Benedetti; C A Winter; A Fahnlander; J D Connor; M A Hintz; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

5.  Subtyping of herpes simplex virus.

Authors:  A Vahlne; J Blomberg; S Olofsson; E Lycke
Journal:  Acta Pathol Microbiol Scand B       Date:  1975-10

6.  Identification, transfer, and characterization of cloned herpes simplex virus invasiveness regions.

Authors:  J L Goodman; M L Cook; F Sederati; K Izumi; J G Stevens
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Primary and recurrent herpes simplex virus type 2-induced meningitis.

Authors:  T Bergström; A Vahlne; K Alestig; S Jeansson; M Forsgren; E Lycke
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

8.  Herpesvirus hominis type 2 meningoencephalitis following renal transplantation.

Authors:  C C Linnemann; M R First; M M Alvira; J W Alexander; G M Schiff
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

9.  Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection.

Authors:  J T Richards; E R Kern; J C Overall; L A Glasgow
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

10.  Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation.

Authors:  K Kristensson; A Vahlne; L A Persson; E Lycke
Journal:  J Neurol Sci       Date:  1978-02       Impact factor: 3.181

View more
  6 in total

1.  The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.

Authors:  Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
Journal:  Exp Neurol       Date:  2006-10-16       Impact factor: 5.330

2.  Herpes simplex virus type 1-induced encephalitis has an apoptotic component associated with activation of c-Jun N-terminal kinase.

Authors:  Dana Perkins; Kymberly A Gyure; Edna F R Pereira; Laure Aurelian
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

3.  APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis.

Authors:  Peter Gee; Yoshinori Ando; Hiroko Kitayama; Seiji P Yamamoto; Yuka Kanemura; Hirotaka Ebina; Yasushi Kawaguchi; Yoshio Koyanagi
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

4.  The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.

Authors:  D Perkins; E F R Pereira; M Gober; P J Yarowsky; L Aurelian
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Resistance of rat CNS to brain stem infection with herpes simplex virus type 1.

Authors:  T Bergström; N Conradi; E Hansson; A Liljeroth; A Vahlne
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.

Authors:  D Perkins; E F R Pereira; L Aurelian
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.